Sign Up For Migraine News & Information
[ad_1] Find a Migraine Specialist Near You The American Migraine Foundation (AMF) and the American Academy of Neurology (AAN) offer resources that can connect you with headache specialists close to
FDA: ‘Snortable’ Chocolate Powder Is a No-Go
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) is warning consumers about a drink and a “snortable” chocolate powder that claim to be alternatives to illicit street drugs.
Winter Safety Tips | RxWiki
[ad_1] (RxWiki News) Whether you’re ready for them or not, the winter months are upon us. It’s time to make sure your family knows how to stay safe and healthy
The True Burden of Alzheimer’s
[ad_1] (RxWiki News) More than 6 million people in the United States may have Alzheimer’s disease or mild cognitive impairment that can lead to the disease, according to a new
Window Blinds: Safety Threat to Children
[ad_1] (RxWiki News) The cords of window blinds may pose serious risks to children’s health and safety, according to a new study. This study found that nearly 17,000 children younger
Heart Screening May Save Infants’ Lives
[ad_1] (RxWiki News) Newborn testing for critical congenital heart disease may save lives, according to a new study. When the authors of this study analyzed nearly 27 million US births,
New Insulin Product Approved | RxWiki
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a short-acting insulin product to improve blood sugar levels in those with diabetes. The FDA reviewed Admelog through
HIV Risk: Don't Guess, Get a Test
[ad_1] A new report from the Centers for Disease Control and Prevention (CDC) highlighted a seven-month improvement in the time between HIV infection and diagnosis. [ad_2] Source link
Allergens Are Everywhere | RxWiki
[ad_1] (RxWiki News) Most Americans are exposed to multiple allergens, according to the largest indoor allergen study ever conducted in the United States. And for many people, allergen exposure can
New Biosimilar Gets Green Light
[ad_1] (RxWiki News) The US Food and Drug Administration (FDA) has approved a new biosimilar. And it’s the first biosimilar to treat certain breast and stomach cancers. It can be